Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | OZK | IBP |
|---|---|---|
| Price | $46.59 | $191.11 |
| Change today | ▼ 0.25% | ▼ 0.98% |
| Market cap | $5.08B | $5.08B |
| Return, 3 months | -5.9% | -13.8% |
| Return, year to date | +4.2% | -25.4% |
| Return, 1 year | -6.3% | -19.2% |
| P/E (TTM) | 7.7 | 20.6 |
| P/B | 0.9 | 7.9 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | 3.91% | 1.74% |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | – | – |
| Analyst buy share | – | – |
| RSI (14) | 38 | 34 |
| 30-day volatility | 16.9% | 39.7% |
| Max drawdown, 1 year | -17.3% | -43.8% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | – | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
